Neptune Wellness Solutions Inc (NASDAQ:NEPT) (TSE:NTB) was the target of some unusual options trading on Wednesday. Investors purchased 12,009 call options on the stock. This represents an increase of approximately 1,191% compared to the average daily volume of 930 call options.
Shares of NASDAQ NEPT opened at $1.75 on Thursday. The firm has a market capitalization of $226.62 million, a price-to-earnings ratio of -3.50 and a beta of 2.49. The stock has a 50 day moving average price of $1.64 and a 200 day moving average price of $2.29. Neptune Wellness Solutions has a 52-week low of $0.96 and a 52-week high of $3.58.
Neptune Wellness Solutions (NASDAQ:NEPT) (TSE:NTB) last announced its quarterly earnings results on Thursday, November 19th. The biotechnology company reported ($0.18) earnings per share (EPS) for the quarter, missing analystsâ€™ consensus estimates of ($0.07) by ($0.11). The firm had revenue of $21.53 million during the quarter, compared to analystsâ€™ expectations of $23.43 million. Neptune Wellness Solutions had a negative net margin of 97.35% and a negative return on equity of 46.39%. Equities research analysts anticipate that Neptune Wellness Solutions will post -0.39 earnings per share for the current year.
A number of institutional investors have recently bought and sold shares of the business. Perceptive Advisors LLC lifted its holdings in Neptune Wellness Solutions by 5.4% during the third quarter. Perceptive Advisors LLC now owns 19,436,906 shares of the biotechnology companyâ€™s stock worth $41,012,000 after buying an additional 1,000,000 shares during the period. AdvisorShares Investments LLC lifted its holdings in Neptune Wellness Solutions by 23.5% during the third quarter. AdvisorShares Investments LLC now owns 527,038 shares of the biotechnology companyâ€™s stock worth $1,112,000 after buying an additional 100,366 shares during the period. Commonwealth Equity Services LLC lifted its holdings in Neptune Wellness Solutions by 88.0% during the second quarter. Commonwealth Equity Services LLC now owns 154,240 shares of the biotechnology companyâ€™s stock worth $431,000 after buying an additional 72,195 shares during the period. Cambria Investment Management L.P. lifted its holdings in Neptune Wellness Solutions by 23.5% during the third quarter. Cambria Investment Management L.P. now owns 89,082 shares of the biotechnology companyâ€™s stock worth $188,000 after buying an additional 16,968 shares during the period. Finally, Bank of America Corp DE lifted its holdings in Neptune Wellness Solutions by 221.9% during the second quarter. Bank of America Corp DE now owns 80,958 shares of the biotechnology companyâ€™s stock worth $226,000 after buying an additional 55,807 shares during the period. Institutional investors own 15.52% of the companyâ€™s stock.
Several research analysts have issued reports on NEPT shares. Zacks Investment Research lowered Neptune Wellness Solutions from a â€œholdâ€ rating to a â€œsellâ€ rating in a report on Wednesday, November 18th. BidaskClub upgraded Neptune Wellness Solutions from a â€œstrong sellâ€ rating to a â€œsellâ€ rating in a report on Wednesday, October 7th.
Neptune Wellness Solutions Company Profile
Neptune Wellness Solutions Inc, a health and wellness products company, specializes in the extraction, purification and formulation of cannabis products, as well as other specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils.
Recommended Story: Google Finance
Receive News & Ratings for Neptune Wellness Solutions Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Neptune Wellness Solutions and related companies with MarketBeat.com’s FREE daily email newsletter.